SeqMatic Lists Services On the Genohub Next Generation Sequencing Market

We want to welcome SeqMatic to the Genohub family. The sequencing services listed by SeqMatic will add more available options to the Genohub next generation sequencing market.

SeqMatic listed the following next generation sequencing instruments and library prep options:

  • Instruments:
    • Illumina GAIIx
    • Illumina MiSeq v2
    • Illumina MiSeq
  • Library prep:
    • Illumina Directional RNA (polyA-selected)
    • Illumina Directional RNA (rRNA-depleted)
    • Illumina RNA (rRNA-depleted)
    • Illumina RNA (polyA-selected)
    • Illumina DNA
    • Illumina Small RNA (microRNA)

SeqMatic’s founders are former Illumina R&D scientists who are experts in the field of next generation sequencing and related bioinformatics services. They specialize in miRNA and mRNA sequencing as well as custom sequencing project services with fast turnaround times. We look forward to matching SeqMatic with the most compatible high throughput sequencing projects for their lab.

The Institute for Personalized and Predictive Medicine of Cancer (IMPPC) Lists High Throughput Sequencing Services On the Genohub Market

We want to welcome The Institute for Personalized and Predictive Medicine of Cancer (IMPPC) to the Genohub family. The high throughput sequencing services listed by IMPPC will add more available options to the Genohub next generation sequencing market.

IMPCC listed the following next generation sequencing instruments and library prep options:

  • Instruments:
    • Illumina HiScanSQ
    • Ion PGM 314 Chip
    • Ion PGM 316 Chip
    • Ion PGM 318 Chip
  • Library prep:
    • Illumina Directional RNA (polyA-selected)
    • Illumina Small RNA (microRNA)
    • Ion DNA

The IMPCC is a publicly funded institute backed by a private foundation with a mission to advance in the understanding of genetic and epigenetic factors leading to higher predisposition or susceptibility to develop cancer. We look forward to matching IMPPC with the most compatible high throughput sequencing projects for their lab.

Axeq Technologies Lists High Throughput Sequencing Services on the Genohub Market

We want to welcome Axeq Technologies to the Genohub family. Axeq has listed high throughput sequencing services if offers on the Genohub next generation sequencing market. Axeq currently has 4 worldwide sites:

  • HQ – Axeq USA in Maryland
  • Axeq Europe in Amsterdam
  • Axeq Asia in Seoul
  • Axeq Japan in Tokyo

Macrogen is the parent company of Axeq which has been a phenomenal success in both the scientific services market and in the field of original genetic research. With devotion to molecular biology, cell biology, genetics research, and extensive investment in installations of cutting-edge research tools – including genotyping, Sanger sequencing and next-generation sequencing platforms, Macrogen successfully published numerous articles in leading journals. These include the publication of the first whole genome sequence of a Korean (Nature), and high resolution CNV analysis of the Asian population (Nature Genetics).

Axeq Technologies was formed in early 2011 as a premium brand to offer both scientific services and collaborations to researchers around the world. The company is dedicated to providing a whole new level of service experience based on its ability to provide publication-quality data and 24/7 client support. Currently, Axeq has listed high throughput sequencing services on an Illumina GAIIx instrument. We look forward to matching Axeq with sequencing projects on the Genohub next generation sequencing market.

University of Rochester Genomics Research Center Adds High Throughput Sequencing Services to Genohub

We want to welcome the University of Rochester Genomics Research Center to the Genohub family. The high throughput sequencing services listed by the University of Rochester will add more available options to the Genohub next generation sequencing market.

The University of Rochester added the following instruments and library prep options:

  • Instruments: Illumina HiSeq
  • Library prep: a host of Illumina options
    • Directional RNA (rRNA-depleted)
    • Directional RNA (polyA-selected)
    • Small RNA (microRNA)
    • ChIP
    • Mate Pair (1-6 kb)
    • DNA
    • Bisulfite
    • RNA (polyA-selected)

We look forward to matching the University of Rochester with the most compatible high throughput sequencing orders for their lab.

Genohub Next Generation Sequencing Market Open to Researchers

RESEARCHERS! SAVE TIME & MONEY ON YOUR NEXT NEXT GENERATION SEQUENCING PROJECT!

The Genohub next generation sequencing market opens today to a number of researchers who could benefit from placing their next-gen sequencing order through Genohub. If you would like to take part in our initial launch please visit our shopping page, enter a few bits of information such as the number of samples to sequence and minimum number of reads, or coverage per sample, and we will instantly match you with the best providers for your project. You also have the ability to search by specific technology if you require a service provider with specific platforms and library types. It is 100% free to search and place an order, and we are currently offering free consultation from our science staff.

Here are some of the other ways we help researchers on Genohub:

  1. Save time shopping for the best price on costly sequencing projects

  2. Eliminate the need for researching the technologies in order to find suitable sequencing solutions

  3. Offer more predictability on turnaround time and quality

  4. Centralized per-project communication platform

Of course we realize that you have a number of options available when it comes to finding the best next generation sequencing provider for your project. In fact, we developed Genohub to help researchers in ways that have not been available up until now. Genohub is unique in that we offer:

  1. Structured service listings

  2. Intelligent technology-aware software that automatically matches project requirements with providers’ service listings

  3. Shopping, ordering and project management process tailored to sequencing projects

As a researcher, we encourage you to visit our shopping page and let us know what you think! And of course if you need any assistance along the way, we would be more than glad to help.

5 Next Generation Sequencing Market Drivers and Hindrances

The next generation sequencing market is poised to reach $2.7 billion by 2017 as presented by marketsandmarkets.com. This represents an estimated growth of 16.3% from a market value of $1.3 billion in 2012. Marketsandmarkets presents a detailed analysis of their findings from which the following top next generation sequencing market drivers and hindrances are derived:

5 Top NGS Market Drivers:

  1. Continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs
  2. Improved turnaround time
  3. Government funding
  4. Increasing opportunities in NGS clinical applications
  5. Presence of dominant NGS platform players

Although the next generation sequencing market is growing rapidly, there are factors which have been weighing down the market as a whole.

5 Top NGS Market Hindrances:

  1. High reliability on grants and funding from the government
  2. Decrease in capital expenditure from academic institutions
  3. Accuracy and standardization concerns
  4. Data storage problems
  5. Issues in interpretation of complex data

The future of the NGS market promises to offer a simpler, less costly, and more integrated experience for researchers. The market is also poised to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research.

Longhorn Vaccines and Diagnostics Adds High Throughput Sequencing Services to Genohub

We want to welcome Longhorn Vaccines and Diagnostics to the Genohub family. The high throughput sequencing services listed by Longhorn will add more available options to the Genohub next generation sequencing market.

Longhorn Vaccines added the following instruments and library prep options:

  • Instruments: Ion PGM 314 Chip, and Ion PGM 318 Chip
  • Library prep: Ion Amplicon, and Ion total RNA

We look forward to matching Longhorn Vaccines with the most compatible high throughput sequencing orders for their lab.

Dr Luke Daum and team at Longhorn Diagnostics also provided us with some excellent feedback on the Genohub platform. At Genohub we strive to maintain a close ear to our clients and continue to improve the experience and service we provide based directly on feedback. We look forward to incorporating suggestions by the Longhorn team into future Genohub iterations.